The UK's bioscience research base is one of the country's genuine long-term economic assets. It is critically important for the UK not to repeat past mistakes, when financial exploitation of innovative and groundbreaking bioresearch went overseas. This study reviews commercialization from the Department of Biological Sciences at Warwick University as a microcosm of the current state of technology transfer in academia. Its technology transfer operation is typical of many other such organizations. Warwick University does, however, have the benefit of being in the "Ivy League" of UK universities and is regarded as a beacon of entrepreneurial flair. If the power of academic entrepreneurship is to be fully unleashed anywhere, Warwick is as well placed as any to capitalize on the opportunities. While the purpose of the study has been to consider how Warwick's enormous entrepreneurial prowess can be harnessed for the greater commercialization of its bioscience research, many of the conclusions and recommendations are applicable to other departments and academic institutions worldwide. (Contains 1 table and 9 figures.)